BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2471784)

  • 1. Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line.
    Cannon MJ; Bangham CR
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():79-87. PubMed ID: 2471784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen.
    Pemberton RM; Cannon MJ; Openshaw PJ; Ball LA; Wertz GW; Askonas BA
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2177-82. PubMed ID: 3497222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus.
    Bangham CR; Askonas BA
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():623-9. PubMed ID: 2420922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helper T cell recognition of respiratory syncytial virus in mice.
    Openshaw PJ; Pemberton RM; Ball LA; Wertz GW; Askonas BA
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():305-12. PubMed ID: 2963089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.
    Bembridge GP; Lopez JA; Bustos R; Melero JA; Cook R; Mason H; Taylor G
    J Virol; 1999 Dec; 73(12):10086-94. PubMed ID: 10559323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus recombinant F protein (residues 255-278) induces a helper T cell type 1 immune response in mice.
    Singh SR; Dennis VA; Carter CL; Pillai SR; Moore EG
    Viral Immunol; 2007; 20(2):261-75. PubMed ID: 17603843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells.
    Kulkarni AB; Morse HC; Bennink JR; Yewdell JW; Murphy BR
    J Virol; 1993 Jul; 67(7):4086-92. PubMed ID: 7685408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.
    Stokes KL; Currier MG; Sakamoto K; Lee S; Collins PL; Plemper RK; Moore ML
    J Virol; 2013 Sep; 87(18):10070-82. PubMed ID: 23843644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
    Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
    Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.
    Cannon MJ; Openshaw PJ; Askonas BA
    J Exp Med; 1988 Sep; 168(3):1163-8. PubMed ID: 3262705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recombinant influenza A virus as a vector expressing respiratory syncytial virus fusion protein epitopes.
    Zhang P; Gu H; Bian C; Liu N; Li Z; Duan Y; Zhang S; Wang X; Yang P
    J Gen Virol; 2014 Sep; 95(Pt 9):1886-1891. PubMed ID: 24914066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.
    de Waal L; Süzer Y; Wyatt LS; Sintnicolaas K; Sutter G; Moss B; Osterhaus AD; de Swart RL
    Viral Immunol; 2006; 19(4):669-78. PubMed ID: 17201662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary pulmonary murine cytotoxic T lymphocyte specificity in respiratory syncytial virus pneumonia.
    Gupta R; Yewdell JW; Olmsted RA; Collins PL; Bennink JR
    Microb Pathog; 1990 Jul; 9(1):13-8. PubMed ID: 2077342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.
    Voges B; Vallbracht S; Zimmer G; Bossow S; Neubert WJ; Richter K; Hobeika E; Herrler G; Ehl S
    Cell Immunol; 2007 Jun; 247(2):85-94. PubMed ID: 17904538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses.
    Shao HY; Yu SL; Sia C; Chen Y; Chitra E; Chen IH; Venkatesan N; Leng CH; Chong P; Chow YH
    Vaccine; 2009 Sep; 27(40):5460-71. PubMed ID: 19622401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.
    Shao HY; Lin YW; Yu SL; Lin HY; Chitra E; Chang YC; Sia C; Chong P; Hsu MT; Wei OL; Chow YH
    PLoS One; 2011; 6(9):e25500. PubMed ID: 21980478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication.
    Nicholas JA; Rubino KL; Levely ME; Meyer AL; Collins PL
    Virology; 1991 Jun; 182(2):664-72. PubMed ID: 2024493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.
    Martinez-Sobrido L; Gitiban N; Fernandez-Sesma A; Cros J; Mertz SE; Jewell NA; Hammond S; Flano E; Durbin RK; García-Sastre A; Durbin JE
    J Virol; 2006 Feb; 80(3):1130-9. PubMed ID: 16414990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.